US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 66.630
  • +0.360+0.54%
Close Dec 24 13:00 ET
  • 66.630
  • 0.0000.00%
Post 17:01 ET
12.70BMarket Cap40.14P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomarin Pharmaceutical Q3 2024 Earnings Date

Currency：USDOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
703.31M
745.74M
+42.43M
Beat Est.
+20.98%
+28.28%
+6.03%
EPS
0.52
0.55
+0.03
Beat Est.
+148.10%
+161.90%
+5.57%
Analyst Rating
Strong Buy

Dec 24, 2024

Biomarin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 728.819M--
--2024/Q4-- / 710.202M--
Oct 29, 20242024/Q3745.740M / 703.312M--
Aug 5, 20242024/Q2712.029M / 664.008M--
Apr 24, 20242024/Q1648.833M / 651.814M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 728.819M--
--2024/Q4-- / 710.202M--
Oct 29, 20242024/Q3745.740M / 703.312M--
Aug 5, 20242024/Q2712.029M / 664.008M--
Apr 24, 20242024/Q1648.833M / 651.814M--

Unlock Free Earnings Estimates

Biomarin Pharmaceutical Earnings Reports

  • Biomarin Pharmaceutical | 10-Q: Q3 2024 Earnings Report

    Oct 31 15:06 ET

  • Biomarin Pharmaceutical | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:38 ET

  • Biomarin Pharmaceutical | 10-Q: Q1 2024 Earnings Report

    Apr 26 14:04 ET

  • Biomarin Pharmaceutical | 8-K: BioMarin Reports Record Financial Results for the First Quarter 2024

    Apr 24 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 24, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data